Skip to main content
. 2018 May 31;20(Suppl F):F1–F74. doi: 10.1093/eurheartj/suy019

Table 10.

Risk and benefit of antithrombotic drugs: interaction between factors related to the patient, medication and the quality of care

Drugs Patient Quality of care
  • Potency, dosage

  • Bioavailability

  • Elimination

  • Resistance

  • Therapy duration

  • Age/body weight

  • Renal function

  • Comorbidity (diabetes)

  • Genetic polymorphism

  • Ischaemic and haemorrhage risk

  • Drug selection

  • Type of stent

  • Pharmacological associations

  • Coronary angiography/PCI

  • Gastric protection

PCI, percutaneous coronary intervention.

HHS Vulnerability Disclosure